金融界8月4日消息，上证指数低开高走，中证1000医药卫生指数 (1000医药，H30444)报13651.50点。 从指数持仓来看，中证1000医药卫生指数十大权重分别为：博瑞医药（3.51%）、通化金马 （2.65%）、泽璟制药（2.51%）、众生药业（1.75%）、昭衍新药（1.7%）、安科生物（1.66%）、一 品红（1.63%）、佐力药业（1.59%）、福瑞股份（1.39%）、东诚药业（1.33%）。 从中证1000医药卫生指数持仓的市场板块来看，上海证券交易所占比55.62%、深圳证券交易所占比 44.38%。 从中证1000医药卫生指数持仓样本的行业来看，化学药占比36.28%、医疗器械占比19.30%、中药占比 17.00%、生物药品占比14.30%、医疗商业与服务占比7.16%、制药与生物科技服务占比5.94%。 资料显示，指数样本每半年调整一次，样本调整实施时间分别为每年6月和12月的第二个星期五的下一 交易日。特殊情况下将对指数进行临时调整。当样本退市时，将其从指数样本中剔除。样本公司发生收 购、合并、分拆等情形的处理，参照计算与维护细则处理。当中证1000指数调整样本时，中证1000行 ...

Core Viewpoint - The CSI 1000 Healthcare Index has shown significant growth, with a 4.34% increase over the past month, 12.39% over the last three months, and 16.26% year-to-date [1] Group 1: Index Performance - The CSI 1000 Healthcare Index is currently at 12,486.30 points [1] - The index is based on a sample of liquid and representative securities from each industry, providing diverse investment options [1] Group 2: Index Holdings - The top ten weighted stocks in the CSI 1000 Healthcare Index include: - Zai Lab (3.14%) - Tonghua Golden Horse (3.02%) - Borui Pharmaceutical (2.67%) - Zuoli Pharmaceutical (1.69%) - Rongchang Biologics (1.59%) - Zhaoyan New Drug (1.47%) - Yipinhong (1.44%) - Anke Biologics (1.42%) - Zhongsheng Pharmaceutical (1.42%) - Yifan Pharmaceutical (1.38%) [1] - The index's market distribution shows that the Shanghai Stock Exchange accounts for 55.72%, while the Shenzhen Stock Exchange accounts for 44.28% [1] Group 3: Industry Composition - The industry composition of the CSI 1000 Healthcare Index is as follows: - Chemical drugs: 35.86% - Medical devices: 19.60% - Traditional Chinese medicine: 17.00% - Biological drugs: 14.32% - Medical commerce and services: 7.53% - Pharmaceutical and biotechnology services: 5.69% [2] - The index samples are adjusted biannually, with adjustments occurring on the next trading day after the second Friday of June and December [2]